Medical Testing

Single Covid vaccine dose in Israel 'less effective than we thought'

Thu, 2021-01-21 19:09 — mike kraft

https://www.theguardian.com/world/2021/jan/19/single-covid-vaccine-dose-in-israel-less-effective-than-we-hoped

Israel’s coronavirus tsar has warned that a single dose of the Pfizer/BioNTech vaccine may be providing less protection than originally hoped, as the country reported a record 10,000 new Covid infections on Monday.

In remarks reported by Army Radio, Nachman Ash said a single dose appeared “less effective than we had thought”, and also lower than Pfizer had suggested.

By contrast, those who had received their second dose of the Pfizer vaccine had a six- to 12-fold increase in antibodies, according to data released by Sheba Medical Center in Tel Hashomer on Monday.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Single Covid vaccine dose in Israel 'less effective than we thought'
Log in or register to post comments

South African study: New COVID-19 variant defeats plasma treatment, may reduce vaccine efficacy

Wed, 2021-01-20 21:03 — mike kraft

New COVID-19 variant defeats plasma treatment, may reduce vaccine efficacy The new COVID-19 variant identified in South Africa can evade the antibodies that attack it in treatments using blood plasma from previously recovered patients, and may reduce the efficacy of the current line of vaccines, scientists said on Wednesday. Reuters Staff U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about South African study: New COVID-19 variant defeats plasma treatment, may reduce vaccine efficacy
Log in or register to post comments

Pfizer-BioNTech Covid-19 vaccine works just as well against variant first detected in U.K., study indicates

Wed, 2021-01-20 13:37 — mike kraft

Study: Pfizer Covid-19 vaccine effective with variant first detected in U.K. The paper is a welcome signal that existing vaccines don’t seem to be weakened by the variant in question, known as B.1.1.7. Andrew Joseph STAT

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Trump admin enlists private firm to review some Covid-19 tests

Mon, 2021-01-18 12:37 — mike kraft

Trump admin enlists private firm to review some Covid-19 tests The decision cuts scientists at the Food and Drug Administration out of the process. David Lim POLITICO

The Department of Health and Human Services is paying a private firm to review the accuracy of some Covid-19 tests — the latest example of the department’s political leadership attempting to bypass scientists at the Food and Drug Administration.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Trump admin enlists private firm to review some Covid-19 tests
Log in or register to post comments

COVID-19 testing capacity strained as localities struggle with vaccine staffing

Mon, 2021-01-18 11:02 — mike kraft

COVID-19 testing capacity strained as localities struggle with Local health departments struggling to find enough staff to carry out a massive vaccination campaign are finding that another key weapon against the coronavirus is being threatened: testing capacity. Peter Sullivan TheHill

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about COVID-19 testing capacity strained as localities struggle with vaccine staffing
Log in or register to post comments

ANALYSIS: Why Aren’t We Wearing Better Masks?

Wed, 2021-01-13 20:20 — mike kraft

Why Aren’t We Wearing Better Masks? Cloth masks are better than nothing, but they were supposed to be a stopgap measure. Zeynep Tufekci, Jeremy Howard The Atlantic

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about ANALYSIS: Why Aren’t We Wearing Better Masks?
Log in or register to post comments

J&J’s one-shot Covid vaccine is safe and generates promising immune response in early trial

Wed, 2021-01-13 19:09 — mike kraft

J&J's one-shot Covid vaccine is safe and generates promising immune response in early trial The new clinical trial data shows a single shot of the vaccine "gives sustainable antibodies," Dr. Paul Stoffels, J&J chief scientific officer, told CNBC. Berkeley Lovelace Jr. CNBC

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about J&J’s one-shot Covid vaccine is safe and generates promising immune response in early trial
Log in or register to post comments

Coronavirus variants may lead to false negative results with molecular tests - FDA

Fri, 2021-01-08 20:24 — mike kraft

Coronavirus variants may lead to false negative results with molecular tests - FDA The U.S. drugs regulator said on Friday genetic variants of COVID-19, including the one found in the UK, could lead to false negative results from some molecular COVID-19 tests, but the risk of the mutations affecting overall testing accuracy is low. Vishwadha Chander U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Coronavirus variants may lead to false negative results with molecular tests - FDA
Log in or register to post comments

Los Angles, Congress take divergent paths after COVID test warning

Fri, 2021-01-08 20:18 — mike kraft

LA, Congress take divergent paths after COVID test warning LOS ANGELES (AP) — Los Angeles will continue using a coronavirus test that federal regulators warned may produce false results while Congress, which has used the same test, is seeking an... AP NEWS

LOS ANGELES (AP) — Los Angeles will continue using a coronavirus test that federal regulators warned may produce false results while Congress, which has used the same test, is seeking an alternative.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Los Angles, Congress take divergent paths after COVID test warning
Log in or register to post comments

HHS Announces $22 Billion in Funding to Support Expanded COVID Testing, Vaccination Distribution

Fri, 2021-01-08 14:31 — mike kraft

Coronavirus Disease 2019 CDC is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, China. Centers for Disease Control and Prevention

The Department of Health and Human Services (HHS) today announced two upcoming actions by the Centers for Disease Control and Prevention (CDC) to provide more than $22 billion in funding to states, localities, and territories in support of the nation’s response to the COVID-19 pandemic, as directed by the Coronavirus Response and Relief Supplemental Appropriations Act.

Country / Region Tags:

General Topic Tags: